70 related articles for article (PubMed ID: 2889827)
1. Differential serotonin2 receptor recovery in mature and senescent rat brain after irreversible receptor modification: effect of chronic reserpine treatment.
Battaglia G; Norman AB; Creese I
J Pharmacol Exp Ther; 1987 Oct; 243(1):69-75. PubMed ID: 2889827
[TBL] [Abstract][Full Text] [Related]
2. Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: a key to receptor regulatory mechanisms.
Norman AB; Battaglia G; Creese I
J Neurosci; 1987 May; 7(5):1484-91. PubMed ID: 2952771
[TBL] [Abstract][Full Text] [Related]
3. Age-related differential recovery rates of rat striatal D-1 dopamine receptors following irreversible inactivation.
Battaglia G; Norman AB; Creese I
Eur J Pharmacol; 1988 Jan; 145(3):281-90. PubMed ID: 2895004
[TBL] [Abstract][Full Text] [Related]
4. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
Lyon RA; Davis KH; Titeler M
Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
[TBL] [Abstract][Full Text] [Related]
5. Long term treatment with desipramine increases the turnover of alpha 2-adrenoceptors in the rat brain.
Barturen F; Garcia-Sevilla JA
Mol Pharmacol; 1992 Nov; 42(5):846-55. PubMed ID: 1359398
[TBL] [Abstract][Full Text] [Related]
6. Relationship between alpha 2-adrenergic receptor binding sites and the functional receptors inhibiting norepinephrine release in rat cerebral cortex.
Nasseri A; Minneman KP
Mol Pharmacol; 1987 Nov; 32(5):655-62. PubMed ID: 2891027
[TBL] [Abstract][Full Text] [Related]
7. Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline.
Peroutka SJ; Snyder SH
J Pharmacol Exp Ther; 1980 Dec; 215(3):582-7. PubMed ID: 6255132
[TBL] [Abstract][Full Text] [Related]
8. Noradrenergic denervation alters serotonin2-mediated behavior but not serotonin2 receptor number in rats: modulatory role of beta adrenergic receptors.
Eison AS; Yocca FD; Gianutsos G
J Pharmacol Exp Ther; 1988 Aug; 246(2):571-7. PubMed ID: 2900327
[TBL] [Abstract][Full Text] [Related]
9. Receptor alterations associated with serotonergic agents: an autoradiographic analysis.
Wamsley JK; Byerley WF; McCabe RT; McConnell EJ; Dawson TM; Grosser BI
J Clin Psychiatry; 1987 Mar; 48 Suppl():19-25. PubMed ID: 3029045
[TBL] [Abstract][Full Text] [Related]
10. Enhanced alpha2A-autoreceptor reserve for clonidine induced by reserpine and cholinomimetic agents in the rat vas deferens.
Pineda J; Ugedo L; García-Sevilla JA
Br J Pharmacol; 1997 Nov; 122(5):833-40. PubMed ID: 9384498
[TBL] [Abstract][Full Text] [Related]
11. 3-H-ketanserin (serotonin type 2) binding in the rat frontal cortex: effect of immobilization stress.
Torda T; Culman J; Cechová E; Murgas K
Endocrinol Exp; 1988 Jun; 22(2):99-105. PubMed ID: 3261685
[TBL] [Abstract][Full Text] [Related]
12. Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade.
Neve KA; Molinoff PB
Mol Pharmacol; 1986 Aug; 30(2):104-11. PubMed ID: 3016496
[TBL] [Abstract][Full Text] [Related]
13. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
Stratford CA; Tan GL; Hamblin MW; Ciaranello RD
Mol Pharmacol; 1988 Oct; 34(4):527-36. PubMed ID: 3139989
[TBL] [Abstract][Full Text] [Related]
14. Adaptation of brain 5HT2 receptors after mianserin treatment: receptor sensitivity, not receptor binding, more accurately correlates with behavior.
Smith RL; Barrett RJ; Sanders-Bush E
J Pharmacol Exp Ther; 1990 Aug; 254(2):484-8. PubMed ID: 2166792
[TBL] [Abstract][Full Text] [Related]
15. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) administration for studies of 5-HT1A receptor binding site inactivation and turnover.
Keck BJ; Lakoski JM
Brain Res Brain Res Protoc; 1997 Oct; 1(4):364-70. PubMed ID: 9384817
[TBL] [Abstract][Full Text] [Related]
16. Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines.
Nelson DL; Lucaites VL; Audia JE; Nissen JS; Wainscott DB
J Pharmacol Exp Ther; 1993 Jun; 265(3):1272-9. PubMed ID: 8510008
[TBL] [Abstract][Full Text] [Related]
17. Repeated peripheral administration of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin alters the binding activities of 5-HT1A and 5-HT2 receptors in rat brain.
Muguruma K; Imamura K; Watanabe Y
Biochem Biophys Res Commun; 1996 Oct; 227(3):794-9. PubMed ID: 8886012
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery.
Battaglia G; Norman AB; Newton PL; Creese I
J Neurochem; 1986 Feb; 46(2):589-93. PubMed ID: 2934516
[TBL] [Abstract][Full Text] [Related]
19. Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: evidence for differences in receptor production and degradation.
Pinto W; Battaglia G
Mol Pharmacol; 1994 Dec; 46(6):1111-9. PubMed ID: 7808431
[TBL] [Abstract][Full Text] [Related]
20. [In vivo study of central serotoninergic receptors in man using positron tomography].
Baron JC; Samson Y; Comar D; Crouzel C; Deniker P; Agid Y
Rev Neurol (Paris); 1985; 141(8-9):537-45. PubMed ID: 2935920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
